Similar Articles
271 Mapping research trends of transarterial chemoembolization for hepatocellular carcinoma from 2012 to 2021: A bibliometric analysis
272 Cellular senescence throws new insights into patient classification and pharmacological interventions for clinical management of hepatocellular carcinoma
273 Fibrinogen-to-albumin ratio predicts overall survival of hepatocellular carcinoma
274 Suberoylanilide hydroxamic acid upregulates reticulophagy receptor expression and promotes cell death in hepatocellular carcinoma cells
275 High spindle and kinetochore-associated complex subunit-3 expression predicts poor prognosis and correlates with adverse immune infiltration in hepatocellular carcinoma
276 Long-term survival of patients with hepatocellular carcinoma with hepatic, pulmonary, peritoneal and rare colon metastasis: A case report
277 Dysregulated microRNAs as a biomarker for diagnosis and prognosis of hepatitis B virus-associated hepatocellular carcinoma
278 Recent progress in understanding mitokines as diagnostic and therapeutic targets in hepatocellular carcinoma
279 Hemocholecyst caused by accidental injury associated with radiofrequency ablation for hepatocellular carcinoma: A case report
280 Prognostic role of metformin in diabetes mellitus type 2 patients with hepatocellular carcinoma: A systematic review and meta-analysis
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA